AKR1B1 is an aldo-keto reductase (AKR), which plays a role in cellular defense and signaling, and is involved in complications of diabetes and tumor progression in basal-like breast cancer (BLBC), CRC, lung cancer, and pancreatic cancer [56–62]. Here, AKR1B1 is linked to colorectal carcinoma.